<DOC>
	<DOC>NCT02583139</DOC>
	<brief_summary>The purpose of this study is to determine whether a specially-designed music-narratives are effective in reducing side effects of chemotherapy in 7- to 12-year-olds with cancer.</brief_summary>
	<brief_title>Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer</brief_title>
	<detailed_description>(Will be added later)</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<criteria>1. Children at the ages 712 2. Four or five (dependent on their overall plan of medical treatment) consecutive courses of chemotherapy administrated at the involved child cancer units and (administered) over a period of minimum 24 hours incl. hydration with assumed moderate to severe nausea and vomiting. The specific type of chemotherapy may vary across the four/five consecutive courses but shall include one of the following moderate and/or highly emetogenic types of chemotherapy: Moderate emetogenic chemotherapy: Carboplatin Cyclophosphamide &lt;1500 mg/m2 Cytarabine &gt;1 g/m2 Daunorubicin Doxorubicin Epirubicin Idarubicin Ifosfamide Mitoxantrone Methotrexate &gt;1000 mg/m2 Highly emetogenic chemotherapy: Cisplatin &gt;25 mg/m2 Cyclophosphamide &gt;1500 mg/m2 Dacarbazine 3. Understand Norwegian/Danish 4. Parents must be able to read and understand Norwegian/Danish No significant hearing impairment Written and verbal informed consent from both possessors of the custody Verbal informed consent from child/participant Previous and/or acute psychiatric diagnosis Cognitive and mental deficits or impaired functioning</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Children, Moderate and/or highly emetogenic chemotherapy</keyword>
</DOC>